Table 10.
Difference of metabolic factors before and after ezetimibe treatments for the reduction of homeostasis model assessment of insulin resistance
Metabolic factors | HOMA-IR at baseline | HOMA-IR at 24 weeks | P-value |
---|---|---|---|
Hypertension (n = 57) | 2.10 | 2.11 | 0.879 |
Dyslipidemia (n = 37) | 2.46 | 2.33 | 0.556 |
Diabetes mellitus (n = 21) | 4.04 | 3.42 | 0.622 |
HOMA-IR, homeostasis model assessment of insulin resistance.